Novagant Financials
This page shows Novagant (NVGT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Novagant’s recovered product-level margin is being overwhelmed by overhead growth and a liability-heavy balance sheet, not by weak sales alone.
Gross margin rebounded from27.5% to40.0% . Yet SG&A grew faster than gross profit, reaching$114K against only$63K in FY2023, so the earnings problem now sits in the operating cost structure rather than in product-level economics alone, which is a very different issue from simply selling at poor margins.
Even after a net loss, operating cash flow stayed positive at
Liquidity is tighter than the cash balance suggests: FY2023 cash was
Financial Health Signals
Based on FY2023 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Novagant's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Novagant has an operating margin of -32.3%, meaning the company retains $-32 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses.
Novagant's revenue surged 50.3% year-over-year to $157K, reflecting rapid business expansion. This strong growth earns a score of 32/100.
Novagant's current ratio of 0.13 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Novagant passes 4 of 9 financial strength tests. 2 of 3 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Novagant generates $-0.10 in operating cash flow ($5K OCF vs -$51K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Novagant earns $-219.4 in operating income for every $1 of interest expense (-$51K vs $231). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Novagant generated $157K in revenue in fiscal year 2023. This represents an increase of 50.3% from the prior year.
Novagant's EBITDA was -$44K in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.
Novagant reported -$51K in net income in fiscal year 2023.
Cash & Balance Sheet
Novagant held $38K in cash against $0 in long-term debt as of fiscal year 2023.
Novagant had 494M shares outstanding in fiscal year 2023. This represents an increase of 64.5% from the prior year.
Margins & Returns
Novagant's gross margin was 40.0% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is up 12.6 percentage points from the prior year.
Novagant's operating margin was -32.3% in fiscal year 2023, reflecting core business profitability.
Novagant's net profit margin was -32.4% in fiscal year 2023, showing the share of revenue converted to profit.
Capital Allocation
NVGT Income Statement
| Metric | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14K+34.5% | $11K+55.1% | $7K-59.7% | $17K-42.8% | $29K-44.6% | $53K-8.4% | $58K+115.0% | $27K |
| Cost of Revenue | $7K+33.9% | $5K+83.7% | $3K-57.6% | $7K-54.8% | $15K-51.7% | $31K-23.1% | $41K+118.0% | $19K |
| Gross Profit | $7K+35.1% | $5K+33.7% | $4K-61.1% | $10K-29.9% | $14K-34.4% | $22K+26.5% | $17K+108.4% | $8K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $26K+24.1% | $21K-3.7% | $21K-54.3% | $47K+61.4% | $29K+22.2% | $24K+72.5% | $14K | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$19K-20.2% | -$16K+12.0% | -$18K+52.4% | -$37K-146.2% | -$15K-594.8% | -$2K-165.5% | $3K | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NVGT Balance Sheet
| Metric | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $33K-25.3% | $44K+0.6% | $43K-16.5% | $52K-15.4% | $61K-15.0% | $72K+48.3% | $49K-11.0% | $55K |
| Current Assets | $27K-25.0% | $37K+6.4% | $34K-16.2% | $41K-15.5% | $48K-30.7% | $70K+51.2% | $46K-9.4% | $51K |
| Cash & Equivalents | $23K-23.5% | $30K-3.1% | $31K-19.8% | $38K+1.7% | $38K-8.8% | $41K+11.5% | $37K-7.2% | $40K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $3K-41.5% | $5K+169.6% | $2K+113.7% | $876-90.3% | $9K-66.3% | $27K+253.5% | $8K-21.1% | $10K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $358K+2.2% | $351K+4.7% | $335K+2.8% | $326K+9.2% | $298K+1.4% | $294K+9.6% | $268K-3.4% | $278K |
| Current Liabilities | $358K+2.7% | $349K+4.2% | $335K+3.4% | $324K+10.0% | $295K+0.2% | $294K+9.6% | $268K-3.4% | $278K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$326K-6.1% | -$307K-5.3% | -$291K-6.4% | -$274K-15.6% | -$237K-6.8% | -$222K-1.0% | -$220K+1.5% | -$223K |
| Retained Earnings | -$3.8M-0.5% | -$3.7M-0.4% | -$3.7M-0.5% | -$3.7M-1.0% | -$3.7M-0.4% | -$3.7M-0.1% | -$3.7M+0.1% | -$3.7M |
NVGT Cash Flow Statement
| Metric | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$5K-700.0% | $866+115.0% | -$6K-333.0% | $2K+10241.7% | $24-99.4% | $4K+337.2% | -$2K-145.6% | $4K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | -$2K-0.1% | -$2K+0.1% | -$2K-0.1% | -$2K+50.0% | -$4K | $0+100.0% | -$1K+33.3% | -$2K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NVGT Financial Ratios
| Metric | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 49.5%+0.2pp | 49.3%-7.9pp | 57.2%-2.1pp | 59.3%+10.9pp | 48.4%+7.6pp | 40.8%+11.3pp | 29.5%-0.9pp | 30.5% |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -131.9%+15.7pp | -147.6%+112.4pp | -260.0%-39.7pp | -220.3%-169.1pp | -51.2%-47.1pp | -4.1%-9.8pp | 5.7% | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -57.2%-21.7pp | -35.5%+5.1pp | -40.6%+30.7pp | -71.3%-46.8pp | -24.5%-21.5pp | -3.0%-9.8pp | 6.8% | N/A |
| Current Ratio | 0.08-0.0 | 0.100.0 | 0.10-0.0 | 0.13-0.0 | 0.16-0.1 | 0.24+0.1 | 0.17-0.0 | 0.18 |
| Debt-to-Equity | -1.10+0.0 | -1.140.0 | -1.15+0.0 | -1.19+0.1 | -1.26+0.1 | -1.33-0.1 | -1.22+0.0 | -1.25 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$274K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.13), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Novagant's annual revenue?
Novagant (NVGT) reported $157K in total revenue for fiscal year 2023. This represents a 50.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Novagant's revenue growing?
Novagant (NVGT) revenue grew by 50.3% year-over-year, from $105K to $157K in fiscal year 2023.
Is Novagant profitable?
No, Novagant (NVGT) reported a net income of -$51K in fiscal year 2023, with a net profit margin of -32.4%.
What is Novagant's EBITDA?
Novagant (NVGT) had EBITDA of -$44K in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.
What is Novagant's gross margin?
Novagant (NVGT) had a gross margin of 40.0% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.
What is Novagant's operating margin?
Novagant (NVGT) had an operating margin of -32.3% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.
What is Novagant's net profit margin?
Novagant (NVGT) had a net profit margin of -32.4% in fiscal year 2023, representing the share of revenue converted into profit after all expenses.
What is Novagant's operating cash flow?
Novagant (NVGT) generated $5K in operating cash flow during fiscal year 2023, representing cash generated from core business activities.
What are Novagant's total assets?
Novagant (NVGT) had $52K in total assets as of fiscal year 2023, including both current and long-term assets.
What is Novagant's current ratio?
Novagant (NVGT) had a current ratio of 0.13 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.
What is Novagant's debt-to-equity ratio?
Novagant (NVGT) had a debt-to-equity ratio of -1.19 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Novagant's return on assets (ROA)?
Novagant (NVGT) had a return on assets of -98.0% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.
Why is Novagant's debt-to-equity ratio negative or unusual?
Novagant (NVGT) has negative shareholder equity of -$274K as of fiscal year 2023, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Novagant's Piotroski F-Score?
Novagant (NVGT) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Novagant's earnings high quality?
Novagant (NVGT) has an earnings quality ratio of -0.10x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Novagant cover its interest payments?
Novagant (NVGT) has an interest coverage ratio of -219.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Novagant?
Novagant (NVGT) scores 5 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.